Lineage Cell Therapeutics, Inc.

Biotechnology company · Carlsbad, California, United States · NYSE: LCTX

Lineage Cell Therapeutics, Inc. is a biotechnology company headquartered in Carlsbad, California, United States. Its shares trade on NYSE under the ticker LCTX. It has received 7 US government small-business research awards (SBIR/STTR) from health agencies, $4.1 million in total, most recently in 2018. It has reported private securities offerings to the US SEC, most recently $3.5 million sold in a notice filed in 2014.

www.biotimeinc.comProfile compiled from public records. Is this your company? Request a correction or update

Lineage Cell Therapeutics at a glance

Typebiotechnology company
HeadquartersCarlsbad, California, United States
Stock listingNYSE: LCTX
SEC industryBiological Products, (No Diagnostic Substances)
Employees (per SBIR records)102
SEC CIK876343

What does Lineage Cell Therapeutics do?

US government research funding

7 SBIR/STTR small-business research awards from US health agencies, $4.1 million in total (2004 to 2018). NIH funding came from the National Eye Institute.

Private fundraising reported to the SEC

9 Form D notices; the most recent reported $3.5 million sold (2014).

Frequently asked questions about Lineage Cell Therapeutics

Where is Lineage Cell Therapeutics headquartered?

Lineage Cell Therapeutics, Inc. is headquartered in Carlsbad, California, United States.

What does Lineage Cell Therapeutics do?

Lineage Cell Therapeutics, Inc. is a biotechnology company. Its SEC industry classification is Biological Products, (No Diagnostic Substances).

Is Lineage Cell Therapeutics a public company?

Yes. Lineage Cell Therapeutics, Inc. trades on NYSE under the ticker LCTX.

Similar companies

Need a CRO or CDMO for your next study?

Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.

Compare quotes

Sources

Location data: GeoNames (geonames.org), CC BY 4.0.

Last updated 2026-09-23.